Adult-to-adult living related donor renal transplantation in Yemen: the first experience.
Between May 1998 and June 2006, 31 patients (21 males and 10 females) received a renal allograft from live-related donors at the Urology and Nephrology Center in the Al-Thawra Modern General Hospital Sana'a, Republic of Yemen. The cold ischemia time ranged between 48 and 68 minutes. The immunosuppressive protocol was double therapy (steroids and mycophenolate) in the first 8 cases. The subsequent cases received triple therapy with steroids, cyclosporine and mycophenolate. Episodes of acute rejection were treated with high dose steroids while anti-thymocyte globulin (ATG) was also used in cases of vascular or steroid resistant rejection. Primary graft function was achieved in 29 recipients (93.5%). The post-transplant complications, either surgical or medical, were comparable to those reported in the literature. The kidney transplantation program started sporadically in Yemen since 1998. However, a well-established program has been running regularly since the beginning of 2005.
El-Nono
Ibrahiem H
IH
Urology and Nephrology Center, Al-Thawra Modern General Hospital, Sana'a, Republic of Yemen. Ibrahim_Elnono@hotmail.com
Al-Ba'adani
Tawfiq H
TH
Ghilan
Abdulilah M
AM
Asba
Nagieb W Abu
NW
Al-Alimy
Gamil M
GM
Al-Massani
Mokhtar M
MM
Noman
Morshed A
MA
Al-Shargabe
Soliman
S
Al-Mansour
Mohamed M
MM
Nassar
Mogahed Y
MY
D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D007674:Kidney Diseases / Q000601:surgery*; D016030:Kidney Transplantation / Q000379:methods / Q000706:statistics & numerical data / Q000639:trends; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012189:Retrospective Studies; D013997:Time Factors; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D015006:Yemen / Q000453:epidemiology
D007166:Immunosuppressive Agents